生物安全
清脆的
中国
业务
工程类
工程伦理学
生物
生物技术
政治学
遗传学
法学
基因
作者
Zandile Nxumalo,Mutsa M. Takundwa,Deepak Raj
出处
期刊:Progress in Molecular Biology and Translational Science
日期:2021-01-01
卷期号:: 345-365
被引量:2
标识
DOI:10.1016/bs.pmbts.2021.01.023
摘要
In this review chapter, we provide full comprehensive analysis on the patent, ethics and biosafety regulation with respect to the application of CRISPR technology in mammalian systems. We focused on recent development in CRISPR technology and its patent landscape between countries such as US, European Union, China and Australia. Further, we emphasized on the current scenarios on the ethics regulations with respect to CRISPR research, its applicability in patent and technology transfer. Finally, we elaborated on the biosafety regulation on CRISPR/Cas9 technology application in both mammalian and non-mammalian host system.
科研通智能强力驱动
Strongly Powered by AbleSci AI